Nikki Duong, Jasmohan Singh Bajaj
Journal: Current opinion in organ transplantation 2021;26(6):587-594
PMID: 34636770
PURPOSE OF REVIEW
Although gut dysbiosis can hasten disease progression in end-stage liver disease and contribute to disease severity, morbidity and mortality, its impact during and after transplant needs further study.
RECENT FINDINGS
Changes in the microbiome are associated with hepatic decompensation. Immune homeostasis is further disrupted during transplant and with immunosuppressants required after transplant. There is increasing evidence of the role of microbiota in peri and posttransplant complications.
SUMMARY
Although transplant is highly successful with acceptable survival rates, infections, rejection, disease recurrence and death remain important complications. Prognostication and interventions involving the gut microbiome could be beneficial.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Full Text Sources:
Medical:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.